Questions discussed in this category
Is there a role for booster vaccination and if so, how do you approach the timing when a patient is already on a biologic for immunosuppression?
For example, in patients who are HbSAg negative, anti-HBc positive and HbSAb negative, does vaccination reduce reactivation risk?
If a deficiency is present, do you consider IVIG to treat non-infectious symptoms such as skin rash, arthritis or hematological abnormalities?
If so, what patients do you recommend get one and do you have concerns for patients who also may be receiving chemotherapy as the CDC guidelines recom...
20930195551845815660100241055610552
Papers discussed in this category
Ann Oncol, 2021 Mar 18
Semin Arthritis Rheum, 2007 Feb
J Clin Rheumatol, 2021 Dec 01
Am J Med, 1984 Mar 30
Lupus, 2007
Autoimmun Rev, 2022 Aug 24
Radiother Oncol, 2015 Aug 04
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-06-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024 Mar 18